Oppenheimer maintains PDS Biotech at 'outperform' with a price target of $23.00 QA

  • Investing.com
Oppenheimer maintains PDS Biotech at 'outperform' with a price target of $23.00 QA

An analyst from Oppenheimer maintained PDS Biotech (NASDAQ: PDSB ) at 'outperform' with a price target of $23.00 from a prior price target of %currency%%price%.

Prior to this rating, PDS Biotech had 7 buy ratings, 0 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on PDS Biotech, click here. For more news on PDS Biotech, click here.

PDS Biotech's stock price closed at $5.03. They are down -8.88% in the last month and down -4.82% in the last 12 months.

According to Investing Pro, PDS Biotech's fair value is $3.59, a downside of 32.69%. PDS Biotech's fair value comes with a high degree of uncertainty, according to InvestingPro.

Check out PDS Biotech's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles